CBD

Trade Group Petitions FDA to Allow CBD Supplements

Posted on November 19, 2019

In the wake of rapidly increasing sales, FDA has continued to maintain that dietary supplements containing hemp-derived cannabidiol (CBD) are illegal under the Federal Food, Drug & Cosmetic Act. FDA

…
Continue Reading Trade Group Petitions FDA to Allow CBD Supplements

FDA and FTC Send Warning Letter for Marketing Unapproved Drugs and Dietary Supplements Containing CBD

Posted on October 23, 2019

On October 10, the FDA and FTC sent a joint warning letter to Rooted Apothecary LLC for illegally selling unapproved drug products containing cannabidiol (CBD) online with unsubstantiated claims that

…
Continue Reading FDA and FTC Send Warning Letter for Marketing Unapproved Drugs and Dietary Supplements Containing CBD

Trade Associations Send Letter to All Members of Congress Urging Action on CBD in Dietary Supplements

Posted on October 11, 2019

On October 8, the American Herbal Products Association, the Consumer Healthcare Products Association, the Council for Responsible Nutrition, and the United Natural Products Alliance – a group of trade associations

…
Continue Reading Trade Associations Send Letter to All Members of Congress Urging Action on CBD in Dietary Supplements

Congress Continues to Seek Regulatory Clarity on CBD from FDA

Posted on September 24, 2019

A bipartisan group of members of Congress sent a letter to FDA on September 19 urging the Agency to quickly provide legal clarity and establish a regulatory pathway for food

…
Continue Reading Congress Continues to Seek Regulatory Clarity on CBD from FDA

Mitch McConnell Introduces Bill Amendment That Would Compel FDA to Issue CBD Enforcement Discretion Policy

Posted on September 19, 2019

Senate Majority Leader Mitch McConnell (R-KY) has introduced language into a Senate appropriations bill that would require FDA to issue temporary guidance on enforcement related to products containing cannabidiol (CBD).

…
Continue Reading Mitch McConnell Introduces Bill Amendment That Would Compel FDA to Issue CBD Enforcement Discretion Policy

FTC Steps Up Enforcement Against CBD Health Claims

Posted on September 12, 2019

CBD-infused products continue to flood the market as the U.S. Food and Drug Administration (FDA) explores additional regulatory pathways for hemp products containing cannabidiol (CBD). Currently, under the Federal Food,

…
Continue Reading FTC Steps Up Enforcement Against CBD Health Claims

Update on the Regulation of CBD-Infused Products

Posted on August 23, 2019

As previously reported on this blog, state regulators want a role in the regulation of CBD-infused food, beverages, and supplements. And while industry has been pressuring FDA to create

…
Continue Reading Update on the Regulation of CBD-Infused Products

FDA Exploring Additional Regulatory Pathways for CBD Products

Posted on July 30, 2019

In testimony before the U.S. Senate Committee on Agriculture, Nutrition, and Forestry on July 25, FDA’s Principal Deputy Commissioner Amy Abernethy, M.D., Ph.D., reiterated that FDA “is committed to advancing

…
Continue Reading FDA Exploring Additional Regulatory Pathways for CBD Products

State AGs Want Role in Regulation of CBD-Containing Products

Posted on July 23, 2019

Many, including state regulators, are closely watching the U.S. Food and Drug Administration (FDA) as it works through the challenges associated with regulating cannabidiol (CBD) products. Under the Federal Food,

…
Continue Reading State AGs Want Role in Regulation of CBD-Containing Products

Bill Introduced to Protect State Cannabis Programs from Federal Interference

Posted on July 2, 2019

As previously reported on this blog, while the 2018 Farm Bill removed hemp from the Controlled Substances Act, its passage did not affect FDA’s authority to regulate cannabidiol (CBD)

…
Continue Reading Bill Introduced to Protect State Cannabis Programs from Federal Interference

menu

The Daily Intake

CBD